Navigation Links
Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint

"We believe Viread has the potential to be an important treatment option for patients with chronic hepatitis B and look forward to sharing detailed data from this study at a scientific conference later this year."

Study 102 is one of two Phase III pivotal studies evaluating the efficacy, safety and tolerability of Viread for the treatment of chronic hepatitis B. The second study (Study 103), a 48-week trial among patients with hepatitis B "e" antigen (HBeAg)-positive chronic hepatitis B, is expected to be complete later this year.

The active ingredient in Viread, tenofovir DF, is currently the most prescribed molecule in the United States for combination HIV therapy. Viread received approval as an anti-HIV medication from the U.S. Food and Drug Administration (FDA) in October 2001 and from the European Commission in February 2002. Viread is not approved as a treatment for chronic hepatitis B, and data from this analysis have not been reviewed by the FDA.

Study Design

Study 102 is a multi-center, randomized, double-blind Phase III clinical trial that compares the efficacy, safety and tolerability of Viread and Hepsera over 48-weeks among patients with HBeAg-negative/anti-HBe positive (presumed pre-core mutant) chronic hepatitis B. Three hundred and seventy-five patients were randomized in a 2:1 ratio to receive either tenofovir DF (300 mg once daily; n=250) or Hepsera (10 mg once daily; n=125).

About Viread (tenofovir disoproxil fumarate)

In the United States, Viread is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. Viread should not be used in combination with the fixed-dose combination products Truvada(R) or Atripla(TM) because they already contain Viread.

Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogues alone or in combination with other antiretrovirals. Viread is not approved for t
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Eisai Limited is pleased ... of the first-of-its-kind comic book available in Canada ... been designed specifically to educate children and their parents about ... affecting more than 300,000 Canadians. Eisai is guided ... (hhc) , in which the patient is central – there ...
(Date:8/21/2014)... 2014 /PRNewswire-iReach/ -- Inc. magazine today ... third straight year, No. 349 in Health on ... of the nation,s fastest-growing private companies. The list ... important segment of the economy—America,s independent entrepreneurs. Companies ... LinkedIn, Zillow, and many other well-known names gained ...
(Date:8/21/2014)... Aug. 21, 2014  Seventy-one percent of Americans believe the ... a serious public health and safety issue in ... survey released today by Repass & Partners, a ... "Americans understand the severity of the prescription medication abuse problem ... this very serious health situation facing our country," Rex ...
Breaking Medicine Technology:Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... Preliminary results,were released today from a late-stage clinical ... study did not meet its primary or secondary,endpoints of ... people with moderate disease., The findings are initial ... known as the EXPLORER study. Rituxan is approved by ...
... 29 Medarex, Inc.,(Nasdaq: MEDX ) announced today ... melanoma, prostate cancer and other cancers, as,well as for ... to be the subject of presentations at the Annual,Meeting ... May,30-June 3, 2008 in Chicago:, Survival, Response, ...
Cached Medicine Technology:Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus 2Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 2Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 3Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 4
(Date:8/23/2014)... (PRWEB) August 23, 2014 Dealing with a ... especially challenging when the addict is a child. Adolescent addiction ... for a long time, but a new helpline is now ... and their parents to find a real addiction recovery center. ... make a positive impact in the community. By calling (404) ...
(Date:8/22/2014)... Search Engine Optimization is needed to ... search engines and get more audience and sales. ... many Linux hosting suppliers and announced that HostGator.com ... recommended Linux hosting suppliers for webmasters from the ... high quality Linux hosting (including VPS and cloud ...
(Date:8/22/2014)... Today, Zane Benefits, the #1 Online ... Health Plans. , According to Zane Benefits, employers are ... lower the cost of healthcare without reducing coverage for ... however, can be confusing. , The new guide contains ... main types of ABHPs. It also explains the ...
(Date:8/22/2014)... 2014 This report studies the ... Handling Systems), Consumables (Tubes), Kits (Isolation, Purification), By ... - Global Forecast to 2018" This market was ... poised to grow at a CAGR of 5.9% ... by 2018. , Browse 98 market data Tables ...
(Date:8/22/2014)... (PRWEB) August 23, 2014 Recently, iFitDress.com, ... its new collection of discounted wedding gowns . ... announced that all these new products are provided with ... are very happy to unveil the new wedding gowns. ... special occasion gowns for ladies to choose from. What’s ...
Breaking Medicine News(10 mins):Health News:Atlanta’s New Troubled Teen Helpline Is Making a Difference in the Community 2Health News:Top10BestSEOHosting.com Announces Best Cheap Hosting Suppliers Of This Summer 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Discounted Wedding Gowns For Sale At Leading Online Shop iFitDress.com 2
... for children,continues to worsen in Myanmar as thousands of ... living in desperate conditions in relief,camps, and some are ... report stated today., The information is contained in ... Myanmar. It details the most urgent needs of women,and ...
... can be bought over the counter and safely used ... When you,re doing your spring cleaning, don,t forget your ... way for people with spring allergies, nasal congestion, stuffy ... Melissa Pynnonen, co-director of the Michigan Sinus Center and ...
... Hospital of Pittsburgh of,UPMC is just one year ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080510/NESA001 ), When the ... will set the,standard for pediatric care nationwide. The ... the multi-phase development project that is,situated on a ...
... against heart disease ... and certain cancers, ARLINGTON, Va., May 8 ... of healthful whole grains, according,to an announcement this week from the U.S. ... bear the whole grain health,claim. This will enable consumers to easily identify ...
... Summary: With the recent devastating,cyclone in Myanmar causing ... people homeless, the need for relief aid is ... launched the Myanmar,Challenge, a grassroots effort to award ... need as much as possible. Setting an initial ...
... May 9 OxyBand Technologies, Inc. today,announced that ... States Army to,evaluate the company,s patented cutting edge ... OxyBand Technologies has developed a,proprietary wound dressing that ... The OxyBand dressing has been shown in clinical ...
Cached Medicine News:Health News:UNICEF REPORT: Desperate Conditions for Children in Camps Without Clean Water as Cyclone Aftermath Worsens 2Health News:UNICEF REPORT: Desperate Conditions for Children in Camps Without Clean Water as Cyclone Aftermath Worsens 3Health News:UNICEF REPORT: Desperate Conditions for Children in Camps Without Clean Water as Cyclone Aftermath Worsens 4Health News:Nasal Irrigation Can Help Fight Spring Allergies 2Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 2Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 3Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 4Health News:FDA Approves Health Claim for Brown Rice 2Health News:FDA Approves Health Claim for Brown Rice 3Health News:FDA Approves Health Claim for Brown Rice 4Health News:FDA Approves Health Claim for Brown Rice 5Health News:New Web Site to Raise Awareness for the Myanmar Crisis Has Lofty Goals 2Health News:OxyBand Technologies Signs Army Contract 2
... introduction of the Leica Dual Imaging Color Module ... available information technology. All important and necessary patient ... M520 / M500 N optical platform on the ... huge amount of benefits: highest brightness, contrast >300:1, ...
... The Leica 2D video ... solutions for microsurgical video imaging. ... an integrated camera module to ... and the Leica 2D C-mount ...
... Headlight mounted micro video camera has ... pictures in areas otherwise invisible to all ... capabilities. The system may be used for ... eliminating crowding of the sterile area and ...
... Sony DXC-990 camera is a 3 chip 1/2 inch ... resolution and a high s/n ratio. It offers picture ... stretch and knee control. The user can choose automatic ... area. The Sony DXC-990 camera is a bayonet mount ...
Medicine Products: